Entities / Company
Moderna.
American biotechnology company
- Reports this week
- 14
- Active events
- 5
- Connections
- 286
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.Some support2 reports
-
Positive test results were reported for Moderna's flu vaccine.Some support2 reports
-
Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.Some support4 reports
-
Dolly Parton, whose roots are in rural Tennessee, donated $1 million to support COVID-19 research involving Moderna and Vanderbilt University.Well supported7 reports
-
Analysis suggests that both Moderna and Illumina stocks are currently overvalued.Some support1 report
Earlier this month
-
Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Some support5 reports
-
Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.Well supported7 reports
-
Moderna and Merck jointly developed and presented intismeran autogene therapy at the ESMO Congress in Madrid.Well supported4 reports
-
Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.Some support2 reports1 development inside
-
Moderna and Novavax partnered with Merck KGaA on an individualized neoantigen program, driven by positive Phase 2b melanoma data.Some support3 reports
-
A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.Some support2 reports
-
Apple Inc., NetApp, and Moderna were mentioned together in a market context on September 13, 2026.Some support1 report
-
Simon Baker downgraded Moderna's stock rating from Neutral to Sell on September 3, 2026.Some support2 reports
-
MarketBeat provided average rating data for Moderna, while CLSA raised the rating and Jefferies reiterated a hold.Some support1 report
-
Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.Well supported18 reports10 developments inside
-
GlaxoSmithKline, Moderna, and Sinovac are leveraging the influenza vaccine market, with Phase 3 trials showing strong immune responses.Some support1 report2 developments inside
-
Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.Well supported5 reports
-
Moderna's higher pricing is contrasted with GSK's and Pfizer's pricing in the context of a joint procurement agreement, which was deemed vital by Hadja Lahbib.Some support1 report
-
Moderna, Tempus, and Merck partnered on the INTerpath-001 trial, which focuses on indications that are covered by Medicare.Some support2 reports
-
Moderna and Merck announced a landmark moment in vaccine testing, alongside updates regarding personnel at Moderna and Columbia University.Some support1 report
-
Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.Some support2 reports
-
Moderna and DaVita are mentioned in the context of sector strength being driven by biotech innovation.Some support1 report
-
Dolly Parton contributed funding to COVID-19 vaccine research and her legacy was celebrated by the city of New York.Some support2 reports
-
Sally Kornbluth leads MIT's academic mission, while Noubar Afeyan connects Moderna and Flagship, with Maura Healey offering support for MIT innovation.Some support1 report
-
Pfizer, BioNTech, Merck KGaA, and Moderna announced joint developments regarding Comirnaty and a new cancer treatment.Some support1 report
-
Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.Some support1 report
-
Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.Some support1 report
-
Moderna and Merck are developing an experimental melanoma vaccine with partners, while concerns about AI models are impacting Gartner's business.Some support2 reports
-
Moderna combined its vaccine with Merck's Keytruda drug.Some support3 reports
-
The event covers Halliburton's expansion into Venezuelan oil fields, Moderna's clinical trial setbacks, and general corporate supply chain trends.Some support1 report
One to three months ago
-
Suze Orman advised against concentration risk in Moderna.Some support2 reports
-
Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.Some support2 reports1 development inside
-
Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.Some support2 reports
-
Stella Parton donated $1 million to support COVID-19 research into mRNA vaccines.Some support1 report
-
Dolly Parton funded research leading to vaccines and removed a Confederate word from an attraction at Dollywood.Some support1 report
-
On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Some support1 report
-
Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.Some support1 report
-
Berkshire Hathaway and Warren Buffett commented on the Moderna and Merck partnership, criticizing market speculation while noting positive news regarding the mRNA vaccine collaboration.Some support1 report
-
Moderna announced updates in Cambridge, MA, led by CEO Stéphane Bancel.Well supported6 reports
-
Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.Some support1 report
-
Royal Bank of Canada and Morgan Stanley provided analyst ratings for Moderna stock.Some support1 report
-
Moderna has established its company headquarters in Cambridge, Massachusetts.Some support3 reports
-
North Carolina donated funds to support the development of Moderna's vaccine.Some support1 report
-
Dolly Parton donated $1 million toward Moderna vaccine research, while Dan Patrick was noted for working as a radio disc jockey in Baltimore.Some support3 reports
-
Dolly Parton donated $1 million to vaccine research and conducted literacy programs in Canada.Well supported10 reports
-
Analyst comments on industry trends regarding Moderna's competition in the cancer vaccine market.Some support1 report
-
Details emerged regarding the early collaboration between Moderna, Pfizer, and the scientific community, including Katalin Karikó and University of Pennsylvania.Some support1 report
-
Dolly Parton launched the Dollywood Foundation in Sevier County to support research leading to a Moderna vaccine.Well supported4 reports2 developments inside
-
Moderna and Merrill jointly developed skin cancer vaccine trials.Some support1 report
-
Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Well supported13 reports1 development inside
-
Moderna and Merck announced initial results from a late-stage trial for their novel cancer treatment.Some support3 reports
-
Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.Some support1 report
-
Moderna and Merck developed personalized mRNA cancer vaccine Intismeran following trial success, leading to a surge in Moderna's shares.Well supported7 reports2 developments inside
-
Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.Some support2 reports
-
Positive Phase 3 data announced from the combined treatment trials involving Moderna and Merck.Well supported3 reports
-
The new event is a composite of two unrelated stories: FED inaction on inflation and successful cancer therapy trial results involving Moderna and Merck.Some support2 reports
-
Moderna and Pfizer announced the successful completion of Phase 3 clinical trials for a novel mRNA cancer treatment.Some support1 report
-
Positive interim readout reported for melanoma trials involving Moderna and Merck.Well supported4 reports
-
Healthcare stocks surged to record highs on August 19, 2026, amid market excitement over drug breakthroughs involving Moderna, Amgen, and Merck.Some support2 reports
-
Moderna and Merck are developing a combination therapy using Keytruda.Well supported7 reports
No events began in the chosen period. Widen it, or reset.
Around Moderna this week
News at the entities that move Moderna most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Moderna
-
Dolly Parton TransactionalKacey Musgraves performed a tribute to Dolly Parton at the 2026 MTV Music Video Awards.Moves Moderna
-
Merck OperationalEli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Moves Moderna
-
Merck KGaA OperationalMSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Moves Moderna
-
Pfizer OperationalDave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Moves Moderna
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves Moderna
Connections
The 40 strongest of 286, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Dolly Parton Transactional
Dolly Parton donated $1 million to Moderna to support early COVID-19 vaccine research and development.
-
Merck Operational
Moderna and Merck are actively collaborating on the joint development and clinical trials of personalized mRNA cancer vaccines.
-
FDA Structural
The FDA formally reviews, guides, and grants market approval for Moderna's products, determining their commercial viability and market launch.
-
Merck KGaA Operational
Merck KGaA and Moderna maintain a strategic partnership focused on jointly developing and testing personalized mRNA cancer vaccines.
-
Novavax Operational
Novavax and Moderna are direct competitors in the vaccine market, vying for market share and facing shared regulatory scrutiny.
-
Nasdaq Structural
Moderna is a company formally listed and trades on the Nasdaq stock exchange.
-
Pfizer Operational
Moderna and Pfizer are direct, high-stakes competitors in the biopharmaceutical market, primarily leveraging and competing within the mRNA technology platform.
-
Stephen Hoge Structural
Stephen Hoge holds the executive role of President at Moderna, overseeing its commercial, R&D, and manufacturing functions.
Show all 40 connections
-
Stéphane Bancel Structural
Stéphane Bancel holds the formal role of Chief Executive Officer of Moderna.
-
Robert Langer Structural
Robert Langer co-founded the biotech firm Moderna.
-
Noubar Afeyan Structural
Noubar Afeyan serves as a cofounder and board chair of Moderna.
-
Food and Drug Administration Structural
The FDA formally evaluates, regulates, and grants market access approvals for Moderna's products.
-
Vanderbilt University Medical Center Structural
Vanderbilt University Medical Center provided foundational research, partnership, and funding integral to Moderna's vaccine development.
-
Centers for Disease Control and Prevention Structural
CDC regulates Moderna's vaccine eligibility and operations, and Moderna receives large government contracts.
-
National Cancer Institute Structural
NCI provides funding for Moderna's mRNA trials and reports on the success of the company's research.
-
David Berman Structural
David Berman serves as the Chief Development Officer at Moderna.
-
European Commission Structural
The European Commission formally approved the mCOMBRIAX vaccine and subsequently entered into a procurement contract with Moderna.
-
CNBC Operational
CNBC actively covers Moderna's corporate announcements and stock movements, while Moderna utilizes CNBC's platform for major communications.
-
Flagship Pioneering Structural
Flagship Pioneering is the founding entity responsible for the creation and structure of Moderna.
-
Health Canada Structural
Health Canada acts as the required regulatory body, providing authorization necessary for Moderna to conduct clinical studies in Canada.
-
Michael McDonnell Structural
Michael McDonnell joined the Board of Directors of Moderna.
-
Mike Structural
Mike holds a formal governance role on the Moderna Board of Directors and Audit Committee.
-
Walgreens Operational
Walgreens serves as a key distribution point, utilizing its locations to make Moderna vaccines available to the public.
-
Donald Trump Structural
Moderna's operations and funding are directly influenced by the policy decisions and regulatory actions of Donald Trump's administration.
-
Coalition for Epidemic Preparedness Innovations Operational
Moderna and CEPI are engaged in a strategic collaboration focused on developing and testing advanced vaccine candidates.
-
Derrick Rossi Structural
Derrick Rossi is a co-founder of the biotechnology company Moderna.
-
Wade Davis Structural
Wade Davis serves as the senior vice president for digital at Moderna.
-
Robert F. Kennedy Jr. Operational
RFK Jr.'s public challenges, lawsuits, and criticisms of mRNA technology actively influence Moderna's market perception and operational environment.
-
Kennedy Operational
Kennedy criticized Moderna's mRNA technology and withdrew research grants for vaccine development.
-
Department of Health & Human Services Structural
Moderna's research, funding, and operational projects are directly dependent on the grants, approvals, and funding decisions made by the Department of Health & Human Services.
-
Democratic Republic of the Congo Operational
Moderna is actively conducting Ebola vaccine trials and supplying vaccines in the Democratic Republic of the Congo.
-
Stella Parton Transactional
Stella Parton made a donation that supported Moderna's research into mRNA vaccines.
-
North Carolina Transactional
North Carolina provided financial donations to support Moderna's vaccine development efforts.
-
end Structural
End manufactures the drug for Moderna, which received FDA approval for its benefit-risk profile.
-
ARE Structural
Moderna operates as a long-term tenant of ARE, which provides life science real estate.
-
American Cancer Society Operational
Moderna's cancer treatment focus aligns with the research and advocacy goals of the American Cancer Society.
-
MSD Operational
Moderna and MSD are actively collaborating on the joint development of intismeran autogene therapy.
-
Eli Lilly and Company Operational
The two companies are direct competitors operating in the high-risk biopharmaceutical and healthcare markets.
-
Gilead Sciences Operational
The companies are major players in the biotech sector and actively compete in the market.
-
Securities and Exchange Commission Structural
Moderna operates under the regulatory oversight of the SEC regarding its share transactions and market filings.
History
Events by the month they beganSeptember 2026
17 events- Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.
- Moderna and Merck jointly developed and presented intismeran autogene therapy at the ESMO Congress in Madrid.
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.
- Moderna and Novavax partnered with Merck KGaA on an individualized neoantigen program, driven by positive Phase 2b melanoma data.
- Apple Inc., NetApp, and Moderna were mentioned together in a market context on September 13, 2026.
- Simon Baker downgraded Moderna's stock rating from Neutral to Sell on September 3, 2026.
- MarketBeat provided average rating data for Moderna, while CLSA raised the rating and Jefferies reiterated a hold.
- Moderna's higher pricing is contrasted with GSK's and Pfizer's pricing in the context of a joint procurement agreement, which was deemed vital by Hadja Lahbib.
- Moderna and Merck announced a landmark moment in vaccine testing, alongside updates regarding personnel at Moderna and Columbia University.
- Moderna and DaVita are mentioned in the context of sector strength being driven by biotech innovation.
- Dolly Parton contributed funding to COVID-19 vaccine research and her legacy was celebrated by the city of New York.
- Sally Kornbluth leads MIT's academic mission, while Noubar Afeyan connects Moderna and Flagship, with Maura Healey offering support for MIT innovation.
- Pfizer, BioNTech, Merck KGaA, and Moderna announced joint developments regarding Comirnaty and a new cancer treatment.
- Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.
- Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.
- Moderna and Merck are developing an experimental melanoma vaccine with partners, while concerns about AI models are impacting Gartner's business.
August 2026
37 events- Dolly Parton, whose roots are in rural Tennessee, donated $1 million to support COVID-19 research involving Moderna and Vanderbilt University.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.
- A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.
- Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.
- Moderna, Tempus, and Merck partnered on the INTerpath-001 trial, which focuses on indications that are covered by Medicare.
- Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.
- Moderna combined its vaccine with Merck's Keytruda drug.
- The event covers Halliburton's expansion into Venezuelan oil fields, Moderna's clinical trial setbacks, and general corporate supply chain trends.
- Suze Orman advised against concentration risk in Moderna.
- Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.
- Stella Parton donated $1 million to support COVID-19 research into mRNA vaccines.
- Dolly Parton funded research leading to vaccines and removed a Confederate word from an attraction at Dollywood.
- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.
- Berkshire Hathaway and Warren Buffett commented on the Moderna and Merck partnership, criticizing market speculation while noting positive news regarding the mRNA vaccine collaboration.
- Moderna, Memorial Sloan Kettering Cancer Center, and American Cancer Society are developing personalized cancer vaccine technology.
- Royal Bank of Canada and Morgan Stanley provided analyst ratings for Moderna stock.
- Moderna has established its company headquarters in Cambridge, Massachusetts.
- North Carolina donated funds to support the development of Moderna's vaccine.
- Dolly Parton donated $1 million toward Moderna vaccine research, while Dan Patrick was noted for working as a radio disc jockey in Baltimore.
- Dolly Parton donated $1 million to vaccine research and conducted literacy programs in Canada.
- Analyst comments on industry trends regarding Moderna's competition in the cancer vaccine market.
- Details emerged regarding the early collaboration between Moderna, Pfizer, and the scientific community, including Katalin Karikó and University of Pennsylvania.
- Dolly Parton launched the Dollywood Foundation in Sevier County to support research leading to a Moderna vaccine.
- Moderna and Merrill jointly developed skin cancer vaccine trials.
- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
- Moderna and Merck announced initial results from a late-stage trial for their novel cancer treatment.
- Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.
- Moderna and Merck developed personalized mRNA cancer vaccine Intismeran following trial success, leading to a surge in Moderna's shares.
- Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
- Positive Phase 3 data announced from the combined treatment trials involving Moderna and Merck.
- The new event is a composite of two unrelated stories: FED inaction on inflation and successful cancer therapy trial results involving Moderna and Merck.
- Moderna and Pfizer announced the successful completion of Phase 3 clinical trials for a novel mRNA cancer treatment.
- Positive interim readout reported for melanoma trials involving Moderna and Merck.
- Healthcare stocks surged to record highs on August 19, 2026, amid market excitement over drug breakthroughs involving Moderna, Amgen, and Merck.
- Moderna and Merck are developing a combination therapy using Keytruda.
June 2026
6 events- Positive test results were reported for Moderna's flu vaccine.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.
- GlaxoSmithKline, Moderna, and Sinovac are leveraging the influenza vaccine market, with Phase 3 trials showing strong immune responses.
- Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.
- Moderna announced updates in Cambridge, MA, led by CEO Stéphane Bancel.